
    
      Participants will be randomly assigned to receive the vaccine or placebo on the selected
      schedule. Safety parameters, solicited injection site and systemic reactions will be
      collected for 6 days after each injection; unsolicited adverse events including serious
      adverse events will be collected up to Day 60 post-vaccination.
    
  